Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Maternal mumps antibodies in a cohort of children up to the age of 1 year.

Leuridan E, Goeyvaerts N, Hens N, Hutse V, Van Damme P.

Eur J Pediatr. 2012 Aug;171(8):1167-73. doi: 10.1007/s00431-012-1691-y. Epub 2012 Mar 7.

PMID:
22395563
2.

Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.

Rafiei Tabatabaei S, Esteghamati AR, Shiva F, Fallah F, Radmanesh R, Abdinia B, Shamshiri AR, Khairkhah M, Shekari Ebrahimabad H, Karimi A.

Arch Iran Med. 2013 Jan;16(1):38-41. doi: 013161/AIM.0012.

3.

Early waning of maternal measles antibodies in era of measles elimination: longitudinal study.

Leuridan E, Hens N, Hutse V, Ieven M, Aerts M, Van Damme P.

BMJ. 2010 May 18;340:c1626. doi: 10.1136/bmj.c1626.

4.

Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.

Johnson CE, Kumar ML, Whitwell JK, Staehle BO, Rome LP, Dinakar C, Hurni W, Nalin DR.

Pediatr Infect Dis J. 1996 Aug;15(8):687-92.

PMID:
8858673
5.

Prevalence of IgG-antibodies to mumps and measles virus in non-vaccinated children.

Glikmann G, Petersen I, Mordhorst CH.

Dan Med Bull. 1988 Apr;35(2):185-7.

PMID:
3359817
6.

Comparison of vaccination with measles-mumps-rubella vaccine at 9, 12, and 15 months of age.

Redd SC, King GE, Heath JL, Forghani B, Bellini WJ, Markowitz LE.

J Infect Dis. 2004 May 1;189 Suppl 1:S116-22.

PMID:
15106100
7.

[Measles and mumps antibody concentrations in newborns and their mothers--follow up first year of life].

Hohendahl J, Peters N, Hüttermann U, Rieger C.

Klin Padiatr. 2006 Jul-Aug;218(4):213-20. German.

PMID:
16819702
8.

Measles-mumps-rubella and varicella vaccine responses in extremely preterm infants.

D'Angio CT, Boohene PA, Mowrer A, Audet S, Menegus MA, Schmid DS, Beeler JA.

Pediatrics. 2007 Mar;119(3):e574-9.

PMID:
17332177
9.

Kinetics of maternal antibodies against rubella and varicella in infants.

Leuridan E, Hens N, Hutse V, Aerts M, Van Damme P.

Vaccine. 2011 Mar 3;29(11):2222-6. doi: 10.1016/j.vaccine.2010.06.004. Epub 2010 Jun 15.

PMID:
20558248
10.

Transfer of measles, mumps, and rubella antibodies from mother to infant. Its effect on measles, mumps, and rubella immunization.

Sato H, Albrecht P, Reynolds DW, Stagno S, Ennis FA.

Am J Dis Child. 1979 Dec;133(12):1240-3.

PMID:
229727
11.

The impact of maternal measles-rubella immunization on the 12-month-old infant's immune response to measles-mumps-rubella vaccine immunogenicity.

Saffar MJ, Ajami A, Khalilian AR, Saffar H.

Eur J Clin Microbiol Infect Dis. 2009 Jul;28(7):845-7. doi: 10.1007/s10096-009-0702-z. Epub 2009 Feb 20.

PMID:
19229565
12.
13.

Measles-mumps-rubella revaccination; 18 months vs. 4-6 years of age: potential impacts of schedule changes.

Saffar MJ, Fathpour GR, Parsaei MR, Ajami A, Khalilian AR, Shojaei J, Saffar H.

J Trop Pediatr. 2011 Oct;57(5):347-51. doi: 10.1093/tropej/fmq102. Epub 2010 Nov 14.

PMID:
21078605
14.
15.

[Seroprevalence of IgG antibodies against measles, mumps and rubella in Swiss children during the first 16 months of life].

Desgrandchamps D, Schaad UB, Glaus J, Tusch G, Heininger U.

Schweiz Med Wochenschr. 2000 Oct 14;130(41):1479-86. German.

PMID:
11075412
16.

Human leukocyte antigen haplotypes in the genetic control of immune response to measles-mumps-rubella vaccine.

Ovsyannikova IG, Pankratz VS, Vierkant RA, Jacobson RM, Poland GA.

J Infect Dis. 2006 Mar 1;193(5):655-63. Epub 2006 Jan 27.

PMID:
16453260
17.
18.

Seroprevalences of Specific IgG Antibodies to Measles, Mumps, and Rubella in Korean Infants.

Cho HK, Lee H, Kim HW, Kim SS, Kang HJ, Kim IT, Kim KH.

J Korean Med Sci. 2016 Dec;31(12):1957-1962. doi: 10.3346/jkms.2016.31.12.1957.

19.

Antibody persistence for 3 years following two doses of tetravalent measles-mumps-rubella-varicella vaccine in healthy children.

Knuf M, Zepp F, Helm K, Maurer H, Prieler A, Kieninger-Baum D, Douha M, Willems P.

Eur J Pediatr. 2012 Mar;171(3):463-70. doi: 10.1007/s00431-011-1569-4. Epub 2011 Sep 21.

PMID:
21935584
20.

Open randomized trial comparing the immunogenicity and safety of a new measles-mumps-rubella vaccine and a licensed vaccine in 12- to 24-month-old children.

Feiterna-Sperling C, Brönnimann R, Tischer A, Stettler P, Durrer P, Gaedicke G.

Pediatr Infect Dis J. 2005 Dec;24(12):1083-8.

PMID:
16371870

Supplemental Content

Support Center